• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND INOGEN; IMPLANTABLE CHF GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND INOGEN; IMPLANTABLE CHF GENERATOR Back to Search Results
Model Number G148
Device Problem Pacing Problem (1439)
Patient Problem Cardiopulmonary Arrest (1765)
Event Date 06/28/2016
Event Type  Injury  
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that the patient implanted with this cardiac resynchronization therapy defibrillator (crt-d) was to undergo an mri.Testing was performed and it was deemed that the patient's intrinsic rhythm was acceptable to undergo the procedure.The crt-d was programmed to mri protection mode prior to mri exposure.Before the mri scan was conducted, the patient became asystolic and required cardiopulmonary resuscitation (cpr).The crt-d was reprogrammed out of mri protection mode and the patient recovered fully.The patient was reported to suffer from intermittent complete atrioventricular (av) block and was hospitalized.The patient was discharged at a later date and the crt-d remains in service.No additional adverse patient effects were reported.Although the crt-d is approved for sale in (b)(6), the software that includes the mri protection mode feature is under clinical trial investigation.This feature, when enabled, suspends bradycardia therapy during the mri scan.This is communicated in the device labeling.Based on the observations, it is likely that the event was due to a previously unrecognized intermittent third degree av block resulting in transient pacemaker dependency.It was confirmed that a future mri scan will not be performed due to these recent changes in the patient's condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN
Type of Device
IMPLANTABLE CHF GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key5795838
MDR Text Key49619260
Report Number2124215-2016-11425
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Reporter Occupation Physician
Type of Report Initial
Report Date 06/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/18/2016
Device Model NumberG148
Other Device ID NumberINOGEN X4 CRT-D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 06/29/2016
Initial Date FDA Received07/14/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/18/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age48 YR
Patient Weight70
-
-